Ionis Pharmaceuticals CEO: High-Profile Partners | Mad Money | CNBC

(8:7)

AMP HF Industry Partners - Ionis Pharmaceuticals, Inc.

(6:51)

Ionis Pharmaceuticals CEO: Our New Name | Mad Money | CNBC

(6:55)

Ionis Pharmaceuticals IONS Q2 2024 Earnings Presentation

(1:9:59)

Rebecca Crean (Ionis Pharmaceuticals) | 2024 FAST Global Summit on Angelman Syndrome

(36:37)

💊 Ionis Pharmaceuticals: A Journey into the Future 🚀 of Investment of IONS Stock 📈 💰 #investing

(4:36)

Ionis Pharmaceuticals IONS Q3 2024 Earnings Presentation

(1:12:38)

Horizon Trial Update (English) - Katy Meilleur PhD, Ionis Pharmaceuticals, Inc

(35:3)

Ionis Pharmaceuticals CEO: Biotech Bounce | Mad Money | CNBC

(7:53)

#TransformedbyYES | Ionis Pharmaceuticals

(1:10)

2023 Ionis Pharmaceuticals Update

(20:57)

The Ionis Predicate: Prior to 1989 | Ionis Pharmaceuticals

(6:41)

Ionis Pharmaceuticals CEO: Healthy Returns | Mad Money | CNBC

(7:27)

Power of YES | Ionis Pharmaceuticals

(1:29)

The Recent Years: 2011-2019 | Ionis Pharmaceuticals

(15:35)

A Culture of YES | Ionis Pharmaceuticals

(55)

Why Ionis

(3:21)

What is Happening Inside the Republic of Gilead? (A Map Analysis)

(9:)

Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed

(3:39)

2025 will be 'fairly challenging' for Moderna: Analyst

(5:6)

The Middle Years: 2000-2010 | Ionis Pharmaceuticals

(5:3)

Brett P. Monia, Ph.D. #throwbackthirty | Ionis Pharmaceuticals

(1:59)